Perceptive-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "NUVL",
  "AXSM",
  "EWTX",
  "CNTA",
  "RGEN",
  "INSM",
  "ARGX",
  "AORT",
  "MDGL",
  "FOLD",
  "ADMA",
  "BSX",
  "MREO",
  null,
  "RCKT",
  "ADPT",
  "ATXS",
  "IMTX",
  "NRIX",
  "ACRV",
  "ADGM",
  "ALDX",
  "AVTX",
  "ATHA",
  "AMLX",
  "JANX",
  "APYX",
  "AVR",
  "APLT",
  null,
  null,
  "CTNM",
  "SYRE",
  "APGE",
  "ISRG",
  null,
  "INBX",
  "NBIX",
  "KALA",
  "LXEO",
  "NAUT",
  null,
  "OKUR",
  null,
  "IOVA",
  "BDSX",
  null,
  "IKT",
  "NBTX",
  null,
  null,
  "PODD",
  "ZYME",
  "RAPT",
  "PTGX",
  "TRAW",
  "SLDB",
  "PRAX",
  "AQST",
  "LYRA",
  "RYTM",
  "SLNO",
  "ACLX",
  "DYN",
  "SCPH",
  null,
  "DCTH",
  "EOLS",
  "EYPT",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "OBIO",
  null,
  "IMVT",
  "PCVX",
  "CRGX",
  "CELC",
  "CGEM",
  "DXCM",
  "IRON",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 86
Total Value: 2694161578
Accession Number: 0001012975-25-000242
Form Type: 13F-HR
CIK: perceptive-advisors
Manager Name: Perceptive-Advisors

Data Enrichment

87% identified

75 identified11 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

86 positions • $2.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Inhibrx Biosciences, Inc.

INBX|45720N103

Shares:1.1M

Value:$14.9M

% of Portfolio:0.6% ($14.9M/$2.7B)

BOSTON SCIENTIFIC CORP

BSX|101137107

Shares:130.0K

Value:$13.1M

% of Portfolio:0.5% ($13.1M/$2.7B)

829401108

Shares:1.3M

Value:$13.1M

% of Portfolio:0.5% ($13.1M/$2.7B)

Inhibikase Therapeutics, Inc.

IKT|45719W205

Shares:5.9M

Value:$13.0M

% of Portfolio:0.5% ($13.0M/$2.7B)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:509.0K

Value:$12.3M

% of Portfolio:0.5% ($12.3M/$2.7B)

DEXCOM INC

DXCM|252131107

Shares:178.0K

Value:$12.2M

% of Portfolio:0.5% ($12.2M/$2.7B)

NEUROCRINE BIOSCIENCES INC

NBIX|64125C109

Shares:100.0K

Value:$11.1M

% of Portfolio:0.4% ($11.1M/$2.7B)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:500.0K

Value:$11.0M

% of Portfolio:0.4% ($11.0M/$2.7B)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:325.3K

Value:$10.9M

% of Portfolio:0.4% ($10.9M/$2.7B)

Acrivon Therapeutics, Inc.

ACRV|004890109

Shares:5.4M

Value:$10.9M

% of Portfolio:0.4% ($10.9M/$2.7B)

Nautilus Biotechnology, Inc.

NAUT|63909J108

Shares:12.6M

Value:$10.8M

% of Portfolio:0.4% ($10.8M/$2.7B)

Aquestive Therapeutics, Inc.

AQST|03843E104

Shares:3.7M

Value:$10.8M

% of Portfolio:0.4% ($10.8M/$2.7B)

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:1.4M

Value:$10.1M

% of Portfolio:0.4% ($10.1M/$2.7B)

CARGO Therapeutics, Inc.

CRGX|14179K101

Shares:2.4M

Value:$9.9M

% of Portfolio:0.4% ($9.9M/$2.7B)

690145206

Shares:833.3K

Value:$9.2M

% of Portfolio:0.3% ($9.2M/$2.7B)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:659.7K

Value:$8.9M

% of Portfolio:0.3% ($8.9M/$2.7B)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:1.5M

Value:$8.3M

% of Portfolio:0.3% ($8.3M/$2.7B)

Adagio Medical Holdings, Inc.

ADGM|00534B100

Shares:9.8M

Value:$7.9M

% of Portfolio:0.3% ($7.9M/$2.7B)

Anteris Technologies Global Corp.

AVR|03675P102

Shares:2.1M

Value:$7.8M

% of Portfolio:0.3% ($7.8M/$2.7B)

Disc Medicine, Inc.

IRON|254604101

Shares:150.0K

Value:$7.4M

% of Portfolio:0.3% ($7.4M/$2.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Inhibrx Biosciences, Inc.(INBXcusip45720N103)	1.1M	QoQ 0.00% (-0) YoY NEW(+1.1M)	All Managers (Combined)	$14.9M	0.6% ($14.9M/$2.7B)	QoQ -9.15% (-$1.5M) YoY NEW(+$14.9M)
BOSTON SCIENTIFIC CORP(BSXcusip101137107)	130.0K	QoQ NEW(+130.0K) YoY NEW(+130.0K)	All Managers (Combined)	$13.1M	0.5% ($13.1M/$2.7B)	QoQ NEW(+$13.1M) YoY NEW(+$13.1M)
(cusip829401108)✕	1.3M	QoQ NEW(+1.3M) YoY NEW(+1.3M)	All Managers (Combined)	$13.1M	0.5% ($13.1M/$2.7B)	QoQ NEW(+$13.1M) YoY NEW(+$13.1M)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	5.9M	QoQ 0.00% (-0) YoY NEW(+5.9M)	All Managers (Combined)	$13.0M	0.5% ($13.0M/$2.7B)	QoQ -32.61% (-$6.3M) YoY NEW(+$13.0M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	509.0K	QoQ -48.88% (-486.9K) YoY -48.79% (-485.1K)	All Managers (Combined)	$12.3M	0.5% ($12.3M/$2.7B)	QoQ -69.32% (-$27.8M) YoY -84.92% (-$69.2M)
DEXCOM INC(DXCMcusip252131107)	178.0K	QoQ NEW(+178.0K) YoY NEW(+178.0K)	All Managers (Combined)	$12.2M	0.5% ($12.2M/$2.7B)	QoQ NEW(+$12.2M) YoY NEW(+$12.2M)
NEUROCRINE BIOSCIENCES INC(NBIXcusip64125C109)	100.0K	QoQ 0.00% (-0) YoY -87.56% (-704.4K)	All Managers (Combined)	$11.1M	0.4% ($11.1M/$2.7B)	QoQ -18.97% (-$2.6M) YoY -90.02% (-$99.9M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	500.0K	QoQ -81.38% (-2.2M) YoY -78.44% (-1.8M)	All Managers (Combined)	$11.0M	0.4% ($11.0M/$2.7B)	QoQ -84.65% (-$60.7M) YoY -74.00% (-$31.3M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	325.3K	QoQ 0.00% (-0) YoY -63.53% (-566.9K)	All Managers (Combined)	$10.9M	0.4% ($10.9M/$2.7B)	QoQ -14.41% (-$1.8M) YoY -71.58% (-$27.5M)
Acrivon Therapeutics, Inc.(ACRVcusip004890109)	5.4M	QoQ 0.00% (-0) YoY +78.22% (-2.4M)	All Managers (Combined)	$10.9M	0.4% ($10.9M/$2.7B)	QoQ -66.27% (-$21.4M) YoY -49.39% (-$10.6M)
Nautilus Biotechnology, Inc.(NAUTcusip63909J108)	12.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$10.8M	0.4% ($10.8M/$2.7B)	QoQ -48.75% (-$10.3M) YoY -70.71% (-$26.2M)
Aquestive Therapeutics, Inc.(AQSTcusip03843E104)	3.7M	QoQ NEW(+3.7M) YoY NEW(+3.7M)	All Managers (Combined)	$10.8M	0.4% ($10.8M/$2.7B)	QoQ NEW(+$10.8M) YoY NEW(+$10.8M)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	1.4M	QoQ 0.00% (-0) YoY NEW(+1.4M)	All Managers (Combined)	$10.1M	0.4% ($10.1M/$2.7B)	QoQ -52.35% (-$11.1M) YoY NEW(+$10.1M)
CARGO Therapeutics, Inc.(CRGXcusip14179K101)	2.4M	QoQ -33.99% (-1.3M) YoY -29.49% (-1.0M)	All Managers (Combined)	$9.9M	0.4% ($9.9M/$2.7B)	QoQ -81.36% (-$43.2M) YoY -87.14% (-$67.1M)
(cusip690145206)✕	833.3K	QoQ NEW(+833.3K) YoY NEW(+833.3K)	All Managers (Combined)	$9.2M	0.3% ($9.2M/$2.7B)	QoQ NEW(+$9.2M) YoY NEW(+$9.2M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	659.7K	QoQ -55.62% (-826.8K) YoY -81.96% (-3.0M)	All Managers (Combined)	$8.9M	0.3% ($8.9M/$2.7B)	QoQ -68.79% (-$19.6M) YoY -86.11% (-$55.1M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	1.5M	QoQ 0.00% (-0) YoY +160.71% (-947.6K)	All Managers (Combined)	$8.3M	0.3% ($8.3M/$2.7B)	QoQ -27.24% (-$3.1M) YoY -31.63% (-$3.9M)
Adagio Medical Holdings, Inc.(ADGMcusip00534B100)	9.8M	QoQ 0.00% (-0) YoY NEW(+9.8M)	All Managers (Combined)	$7.9M	0.3% ($7.9M/$2.7B)	QoQ -23.33% (-$2.4M) YoY NEW(+$7.9M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	2.1M	QoQ 0.00% (-0) YoY NEW(+2.1M)	All Managers (Combined)	$7.8M	0.3% ($7.8M/$2.7B)	QoQ -34.76% (-$4.2M) YoY NEW(+$7.8M)
Disc Medicine, Inc.(IRONcusip254604101)	150.0K	QoQ NEW(+150.0K) YoY -50.00% (-150.0K)	All Managers (Combined)	$7.4M	0.3% ($7.4M/$2.7B)	QoQ NEW(+$7.4M) YoY -60.13% (-$11.2M)